A Multicenter, Randomized, Open-Label Comparison of the Safety and Efficacy of Tigecycline vs Imipenem/Cilastatin to Treat Complicated Intra-Abdominal Infections in Hospitalized Chinese Subjects.

Trial Profile

A Multicenter, Randomized, Open-Label Comparison of the Safety and Efficacy of Tigecycline vs Imipenem/Cilastatin to Treat Complicated Intra-Abdominal Infections in Hospitalized Chinese Subjects.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Tigecycline (Primary) ; Imipenem/cilastatin
  • Indications Bacterial infections; Intra-abdominal infections
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 14 Jul 2009 Actual end date (Dec 2006) added as reported by ClinicalTrials.gov.
    • 12 Dec 2007 Status change from in progress to completed
    • 11 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top